Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02681354
Other study ID # 2015-PFE-JSP-01
Secondary ID
Status Completed
Phase N/A
First received July 6, 2015
Last updated June 13, 2016
Start date November 2015
Est. completion date June 2016

Study information

Verified date June 2016
Source Hasselt University
Contact n/a
Is FDA regulated No
Health authority Belgium: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Mild cognitive impairment (MCI) is accompanied by gait and balance problems while dual tasking. During a 6 to 8 weeks training with the BioRescue (virtual reality), institutionalized elderly people with MCI will relearn dual tasks in combination with balance. Afterwards, the transferring effect on gait in general, balance and cognition will be examined.


Recruitment information / eligibility

Status Completed
Enrollment 21
Est. completion date June 2016
Est. primary completion date January 2016
Accepts healthy volunteers No
Gender Both
Age group 65 Years and older
Eligibility Inclusion Criteria:

- minimum age: 65

- Participants with increased fall-risk (i.e. Timed Up-and-Go Test (TUG) > 20 sec)

- Participants with Mild Cognitive Impairment (MCI) measured by the Montreal Cognitive Assessment (MoCa < 25). MCI: A state of altered cognition, characterized by a decline in one or more cognitive domains, typically including memory while the independence for daily activities remains intact.

- Participants have a positive result on the 'Stops Walking While Talking' test

Exclusion Criteria:

- Diagnosis of Dementia, based on a specialized diagnostic bilan of a doctor-specialist.

- In rehabilitation for a recent injury or recent prothesis of the upper or lower extremities.

- Serious limitations of the lower and or upper limb.

- Not able to walk more than 10 meters independently (walking-aid allowed).

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator)


Related Conditions & MeSH terms


Intervention

Other:
Biorescue training


Locations

Country Name City State
Belgium Hasselt University Diepenbeek
Belgium Woon- en zorgcentrum Sint Elisabeth Hasselt

Sponsors (1)

Lead Sponsor Collaborator
Hasselt University

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Static balance measured using the BioRescue day 1 No
Primary Static balance measured using the BioRescue week 8 No
Primary Dynamic Balance instrumented timed Up-and-Go test day 1 No
Primary Dynamic Balance instrumented timed Up-and-Go test week 8 No
Primary instrumented timed Up-and-Go test while dual-tasking instrumented timed Up-and-Go test while dual-tasking day 1 No
Primary instrumented timed Up-and-Go test while dual-tasking instrumented timed Up-and-Go test while dual-tasking week 8 No
Primary "stops walking while talking" test "stops walking while talking" test day 1 No
Primary "stops walking while talking" test "stops walking while talking" test week 8 No
Secondary fall incidence The incidence of falls for each participant will be registered in the institution up to 8 weeks No
Secondary cognitive function measured by the MOCA (Montreal Cognitive Assesment) day 1 No
Secondary cognitive function measured by the MOCA (Montreal Cognitive Assesment) week 8 No
See also
  Status Clinical Trial Phase
Completed NCT04513106 - Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial N/A
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Active, not recruiting NCT03167840 - Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment N/A
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Not yet recruiting NCT05041790 - A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment Phase 4
Recruiting NCT04121156 - High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment N/A
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Completed NCT02774083 - Cognitive Training Using Feuerstein Instrumental Enrichment N/A
Completed NCT01315639 - New Biomarker for Alzheimer's Disease Diagnostic N/A
Enrolling by invitation NCT06023446 - Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
Completed NCT04567745 - Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers Phase 1
Recruiting NCT05579236 - Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
Completed NCT03583879 - Using Gait Robotics to Improve Symptoms of Parkinson's Disease N/A
Terminated NCT02503501 - Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease Phase 2
Not yet recruiting NCT03740178 - Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) Phase 1
Active, not recruiting NCT05204940 - Longitudinal Observational Biomarker Study
Recruiting NCT02663531 - Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Recruiting NCT03507192 - Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia. N/A